Tenet Healthcare (NYSE:THC) Director Nadja West Sells 1,152 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) Director Nadja West sold 1,152 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $258.80, for a total transaction of $298,137.60. Following the completion of the sale, the director owned 23,653 shares of the company’s stock, valued at $6,121,396.40. This trade represents a 4.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Tenet Healthcare Trading Up 2.0%

THC opened at $263.64 on Friday. Tenet Healthcare Corporation has a 52 week low of $157.58 and a 52 week high of $283.05. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The business has a fifty day simple moving average of $236.52 and a 200-day simple moving average of $210.85. The firm has a market cap of $21.23 billion, a P/E ratio of 10.17, a P/E/G ratio of 0.99 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter in the previous year, the business earned $4.02 EPS. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, equities analysts expect that Tenet Healthcare Corporation will post 21.04 earnings per share for the current year.

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the company. Swedbank AB increased its position in Tenet Healthcare by 14.7% during the fourth quarter. Swedbank AB now owns 146,133 shares of the company’s stock worth $29,040,000 after buying an additional 18,750 shares during the period. Hsbc Holdings PLC grew its position in shares of Tenet Healthcare by 3,478.7% during the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock worth $53,269,000 after acquiring an additional 258,956 shares during the last quarter. Jackson Creek Investment Advisors LLC increased its holdings in shares of Tenet Healthcare by 235.6% in the 4th quarter. Jackson Creek Investment Advisors LLC now owns 9,032 shares of the company’s stock valued at $1,795,000 after acquiring an additional 6,341 shares during the period. Brandywine Global Investment Management LLC raised its position in Tenet Healthcare by 20.5% in the 4th quarter. Brandywine Global Investment Management LLC now owns 126,248 shares of the company’s stock valued at $25,088,000 after purchasing an additional 21,435 shares during the last quarter. Finally, Louisiana State Employees Retirement System acquired a new stake in Tenet Healthcare during the 1st quarter worth $4,812,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on THC. Royal Bank Of Canada upped their target price on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research note on Monday, July 27th. Zacks Research upgraded shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. TD Cowen upped their price objective on Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a report on Monday, July 27th. Finally, Truist Financial upped their price target on Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $273.00.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.